LYTIR

Company · DOCU

DocuSign, Inc.

Name as listed on its exchange; filed with the SEC as DOCUSIGN, INC.

Nasdaq's symbol directory lists DOCU on Nasdaq as “DocuSign, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 19 occasions ($14.8M); 10 planned-sale notices; 1 filing by holders of 5% or more.

All insider filings at the SEC · Appeared in No. 40

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $14.8M in total.Jun: Insider sales $684KJul: Insider sales $2.7MAug: Insider sales $929KSep: Insider sales $7.3MOct: Insider sales $2.9MNov: Insider sales $270KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $14.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. GRAYSON BLAKE JEFFREY, Chief Financial Officer sold on 4 days all under a 10b5-1 plan latest Sep 8, 2026 sold $4.7M
  2. Thygesen Allan C., President and CEO sold on 2 days all under a 10b5-1 plan latest Oct 1, 2026 sold $3.0M
  3. Solvik Peter sold on 1 day latest Sep 10, 2026 sold $3.0M
  4. Chatwani Robert, President General Mgr, Growth sold on 2 days all under a 10b5-1 plan latest Sep 17, 2026 sold $1.7M
  5. Shaughnessy James P, Chief Legal Officer sold on 2 days all under a 10b5-1 plan latest Oct 1, 2026 sold $1.4M
  6. Hansen Paula, Chief Revenue Officer sold on 3 days all under a 10b5-1 plan latest Nov 2, 2026 sold $770K
  7. Wilderotter Mary Agnes sold on 2 days all under a 10b5-1 plan latest Oct 1, 2026 sold $146K
  8. Marrs Anna sold on 1 day all under a 10b5-1 plan latest Sep 14, 2026 sold $37K
  9. Briggs Teresa sold on 1 day all under a 10b5-1 plan latest Sep 10, 2026 sold $35K
  10. BEER JAMES A sold on 1 day all under a 10b5-1 plan latest Aug 28, 2026 sold $29K
Every trade (19)
  1. SELLHansen Paula, Chief Revenue Officer sold Nov 2, 2026 3,300 shares 10b5-1 plan (scheduled) filing $270K
  2. SELLThygesen Allan C., President and CEO sold Oct 1, 2026 26,250 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.8M
  3. SELLShaughnessy James P, Chief Legal Officer sold Oct 1, 2026 12,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $826K
  4. SELLHansen Paula, Chief Revenue Officer sold Oct 1, 2026 3,300 shares 2 legs combined 10b5-1 plan (scheduled) filing $227K
  5. SELLWilderotter Mary Agnes sold Oct 1, 2026 1,000 shares 10b5-1 plan (scheduled) filing $69K
  6. SELLChatwani Robert, President General Mgr, Growth sold Sep 17, 2026 14,676 shares 2 legs combined 10b5-1 plan (scheduled) filing $1.0M
  7. SELLWilderotter Mary Agnes sold Sep 16, 2026 1,096 shares 10b5-1 plan (scheduled) filing $77K
  8. SELLMarrs Anna sold Sep 14, 2026 548 shares 10b5-1 plan (scheduled) filing $37K
  9. SELLSolvik Peter sold Sep 10, 2026 46,000 shares 2 legs combined filing $3.0M
  10. SELLBriggs Teresa sold Sep 10, 2026 548 shares 10b5-1 plan (scheduled) filing $35K
  11. SELLGRAYSON BLAKE JEFFREY, Chief Financial Officer sold Sep 8, 2026 15,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $984K
  12. SELLGRAYSON BLAKE JEFFREY, Chief Financial Officer sold Sep 4, 2026 30,000 shares 10b5-1 plan (scheduled) filing $2.1M
  13. SELLBEER JAMES A sold Aug 28, 2026 450 shares 10b5-1 plan (scheduled) filing $29K
  14. SELLGRAYSON BLAKE JEFFREY, Chief Financial Officer sold Aug 7, 2026 15,000 shares 10b5-1 plan (scheduled) filing $900K
  15. SELLThygesen Allan C., President and CEO sold Jul 1, 2026 26,250 shares 2 legs combined 10b5-1 plan (scheduled) filing $1.2M
  16. SELLGRAYSON BLAKE JEFFREY, Chief Financial Officer sold Jul 1, 2026 15,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $683K
  17. SELLShaughnessy James P, Chief Legal Officer sold Jul 1, 2026 12,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $546K
  18. SELLHansen Paula, Chief Revenue Officer sold Jul 1, 2026 6,000 shares 10b5-1 plan (scheduled) filing $273K
  19. SELLChatwani Robert, President General Mgr, Growth sold Jun 22, 2026 15,902 shares 2 legs combined 10b5-1 plan (scheduled) filing $684K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. PAULA HANSEN filed Nov 2, 2026 Officer 3,300 shares planned sale date 11/02/2026 filing $270K
  2. ALLAN THYGESEN filed Oct 1, 2026 Director 26,250 shares planned sale date 10/01/2026 filing $1.8M
  3. JAMES P SHAUGHNESSY filed Oct 1, 2026 Officer 12,000 shares planned sale date 10/01/2026 filing $826K
  4. PAULA HANSEN filed Oct 1, 2026 Officer 3,300 shares planned sale date 10/01/2026 filing $227K
  5. MARY AGNES WILDEROTTER filed Oct 1, 2026 Director 1,000 shares planned sale date 10/01/2026 filing $69K
  6. ROBERT CHATWANI filed Sep 17, 2026 Officer 14,676 shares planned sale date 09/17/2026 filing $1.0M
  7. MARY AGNES WILDEROTTER filed Sep 16, 2026 Director 1,096 shares planned sale date 09/16/2026 filing $77K
  8. ANNA MARRS filed Sep 14, 2026 Director 548 shares planned sale date 09/14/2026 filing $37K
  9. Peter Solvik filed Sep 10, 2026 Director 30,000 shares planned sale date 09/10/2026 filing $1.9M
  10. TERESA BRIGGS filed Sep 10, 2026 Director 548 shares planned sale date 09/10/2026 filing $35K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. JPMORGAN CHASE & CO. filed Nov 5, 2026 Schedule 13G/A passive 8,964,843 shares filing 4.5%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.